These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1037 related articles for article (PubMed ID: 11125379)
1. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379 [TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. Lau WK; Bergstralh EJ; Blute ML; Slezak JM; Zincke H J Urol; 2002 Jan; 167(1):117-22. PubMed ID: 11743287 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204 [TBL] [Abstract][Full Text] [Related]
4. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? Thompson RH; Blute ML; Slezak JM; Bergstralh EJ; Leibovich BC J Urol; 2007 Aug; 178(2):459-63; discussion 463. PubMed ID: 17561132 [TBL] [Abstract][Full Text] [Related]
5. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502 [TBL] [Abstract][Full Text] [Related]
6. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors. Bloom KD; Richie JP; Schultz D; Renshaw A; Saegaert T; D'amico AV Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484 [TBL] [Abstract][Full Text] [Related]
7. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Freedland SJ; Aronson WJ; Presti JC; Amling CL; Terris MK; Trock B; Kane CJ Cancer; 2004 Apr; 100(8):1633-8. PubMed ID: 15073850 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941 [TBL] [Abstract][Full Text] [Related]
9. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857 [TBL] [Abstract][Full Text] [Related]
10. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725 [TBL] [Abstract][Full Text] [Related]
11. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy. Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734 [TBL] [Abstract][Full Text] [Related]
12. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Valicenti RK; Chervoneva I; Gomella LG Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249 [TBL] [Abstract][Full Text] [Related]
13. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
14. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712 [TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. Lerner SE; Blute ML; Bergstralh EJ; Bostwick DG; Eickholt JT; Zincke H J Urol; 1996 Jul; 156(1):137-43. PubMed ID: 8648775 [TBL] [Abstract][Full Text] [Related]
16. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Blute ML; Bostwick DG; Bergstralh EJ; Slezak JM; Martin SK; Amling CL; Zincke H Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884 [TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Kupelian P; Katcher J; Levin H; Zippe C; Klein E Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737 [TBL] [Abstract][Full Text] [Related]
18. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793 [TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles. Johnson CW; Anastasiadis AG; McKiernan JM; Salomon L; Eaton S; Goluboff ET; Olsson CA; Benson MC Urol Oncol; 2004; 22(2):107-11. PubMed ID: 15082006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]